The impact of mergers on pharmaceutical R&D

被引：0

作者：

John L. LaMattina

机构：

[1] John L. LaMattina is the former President of Pfizer Global Research and Development,

[2] and is currently Senior Partner at Puretech Ventures,undefined

[3] Boston,undefined

[4] Massachusetts 02116,undefined

[5] USA. john.lamattina@comcast.net,undefined

来源：

Nature Reviews Drug Discovery | 2011年 / 10卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Mergers and acquisitions in the pharmaceutical industry have substantially reduced the number of major companies over the past 15 years. The short-term business rationale for this extensive consolidation might have been reasonable, but at what cost to research and development productivity?

引用

页码：559 / 560

页数：1

共 50 条

[1] The impact of mergers on pharmaceutical R&D
LaMattina, John L.
[J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (08) : 559 - 560
[2] Do large mergers increase or decrease the productivity of pharmaceutical R&D?
Ringel, Michael S.
Choy, Michael K.
[J]. DRUG DISCOVERY TODAY, 2017, 22 (12) : 1749 - 1753
[3] Mergers, IPOs, and R&D
Studt, T
[J]. R&D MAGAZINE, 2000, 42 (02): : 9 - 9
[4] The impact of price controls on pharmaceutical R&D investment
Abbott, TA
[J]. VALUE IN HEALTH, 2004, 7 (03) : 380 - 380
[5] Competition, Mergers, and R&D Diversity
Gilbert, Richard J.
[J]. REVIEW OF INDUSTRIAL ORGANIZATION, 2019, 54 (03) : 465 - 484
[6] Competition, Mergers, and R&D Diversity
Richard J. Gilbert
[J]. Review of Industrial Organization, 2019, 54 : 465 - 484
[7] Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan
Mahlich, Joerg C.
[J]. HEALTH ECONOMICS REVIEW, 2014, 4
[8] PHARMACEUTICAL REGULATION IN EUROPE AND ITS IMPACT ON CORPORATE R&D
Mahlich, J.
Eger, S.
[J]. VALUE IN HEALTH, 2013, 16 (07) : A487 - A487
[9] Pharmaceutical regulation in Europe and its impact on corporate R&D
Stephan Eger
Jörg C Mahlich
[J]. Health Economics Review, 4 (1)
[10] The interactions of R&D investments and horizontal mergers
Cabolis, C.
Manasakis, C.
Moreno, D.
Petrakis, E.
[J]. JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION, 2021, 187 : 507 - 534

← 1 2 3 4 5 →